IL-22–producing neutrophils contribute to antimicrobial defense and restitution of colonic epithelial integrity during colitis by Zindl, Carlene L. et al.
IL-22–producing neutrophils contribute to
antimicrobial defense and restitution of colonic
epithelial integrity during colitis
Carlene L. Zindla,b, Jen-Feng Laib, Yun Kyung Leea,c, Craig L. Maynarda, Stacey N. Harboura, Wenjun Ouyangd,
David D. Chaplinb, and Casey T. Weavera,1
Departments of aPathology and bMicrobiology, University of Alabama at Birmingham, Birmingham, AL 35294; cDivision of Biology, California Institute
of Technology, Pasadena, CA 91125; and dDepartment of Immunology, Genentech, South San Francisco, CA 94080
Edited by Philippa Marrack, Howard Hughes Medical Institute, National Jewish Health, Denver, CO, and approved May 22, 2013 (received for review
January 10, 2013)
IL-22 plays an important role in mucosal epithelial cell homeostasis.
Using a dextran sodium sulfate-induced mouse model of acute
colitis,weobservedan IL-23–dependent up-regulationof IL-22 in the
middle and distal colon at the onset of epithelial cell damage. This
heightened IL-22 correlated with an inﬂux of innate immune cells,
suggesting an important role in colonic epithelial protection. Freshly
isolated colon-inﬁltrating neutrophils produced IL-22 contingent
upon IL-23 signaling, and IL-22 production was augmented by TNF-
α. Importantly, the depletion of neutrophils resulted in diminished
IL-22 levels in the colon, and the transfer of IL-22–competent neu-
trophils to Il22a-deﬁcient mice protected the colonic epithelium
from dextran sodium sulfate-induced damage. In addition, IL-22–
producing neutrophils targeted colonic epithelial cells to up-regu-
late the antimicrobial peptides, RegIIIβ and S100A8. This study
establishes a role for neutrophils in providing IL-22–dependent mu-
cosal epithelial support that contributes to the resolution of colitis.
interleukin-22 | intestinal inﬂammation | leukocytes
IL-22 is up-regulated in multiple chronic inﬂammatory diseasesincluding inﬂammatory bowel disease (IBD), asthma, and psoriasis
(1–5). IL-22 acts directly on epithelial and parenchymal cells by
binding to a heterodimer receptor complex consisting of IL10 re-
ceptor 2 (IL-10R2) and IL22 receptor 1 (IL-22R1; IL-22R) (6). Im-
portantly, IL-22 is considered beneﬁcial for intestinal epithelial
barrier function because of increased epithelial cell proliferation,
migration, and mucus production (7, 8). In a mouse model of trans-
missible colitis induced by Citrobacter rodentium, IL-22 was required
for increased expression of RegIII antimicrobial proteins, which
are thought to promote bacterial clearance through direct micro-
bicidal effects (9). Together these studies indicate an important role
for IL-22 in mucosal epithelial antimicrobial defense and integrity.
Polymorphisms in the IL-23 receptor (IL-23R) gene are asso-
ciated with IBD; therefore, the regulation of signals downstream
of the IL-23R such as IL-22 and IL-17 may signiﬁcantly inﬂuence
human susceptibility or resistance to intestinal disease (2, 10).
Early studies demonstrated that IL-17+CD4+ T cells (Th17 cells)
produce IL-22 (1, 11). However, more recent studies demonstrate
that several innate lymphoid cell (ILC) populations produce IL-22
(12, 13). Natural killer (NK) subsets that produce IL-22 have been
identiﬁed in both humans and mice (4, 14–16). In addition, lym-
phoid tissue inducer cells that are crucial for fetal development of
lymphoid tissues and CD11c+ colonic cells stimulated via Toll-like
receptor signals secrete IL-22 (9, 14, 17, 18). Furthermore, studies
using IL-23R reporter mice showed that γδ+ T cells in the lamina
propria of the intestines and some population(s) of CD11b+ cells
also express the IL-23R and therefore may contribute importantly
to IL-22 production in vivo (19).
IBD (including ulcerative colitis and Crohn’s disease) is char-
acterized by abnormal innate and adaptive immune responses. In
IBD and mouse models of colitis, the innate immune response in
the colon includes recruited macrophages and granulocytes, which
appear to have both proinﬂammatory and anti-inﬂammatory roles
in colitis (20). Aberrant control of these innate immune cells can
result in tissue damage in the colon caused by abundant reactive
oxygen species (21–23). However, more recent studies demonstrate
that in acute models of colitis, neutrophils play a protective role in
the host response (24, 25). Here we show that colon-inﬁltrating
neutrophils are induced by IL-23 to produce IL-22 during acute
dextran sodium sulfate (DSS)-induced colitis. In addition, IL-22–
competent neutrophils enhance antimicrobial peptide production
from colon epithelial cells, and their production of IL-22 is critical
to restore the integrity of the epithelium following mucosal injury.
These ﬁndings deﬁne a role for neutrophils in contributing to IL-
22–mediated protection of the colonic epithelial barrier.
Results
IL-22 Levels Parallel Inﬂux of Recruited Innate Immune Cells.Dextran
sodium sulfate (DSS) treatment causes direct epithelial cell damage
and acute colitis in mice. Signiﬁcant numbers of CD11b+Ly6C+
innate cells were recruited to themiddle and distal colon by the end
of the ﬁrst week of DSS treatment (Fig. 1A). Contained within this
population were three distinct innate cell types that could be dis-
tinguished by additional cell-surface markers or side-scatter prop-
erties, as conﬁrmed by transmission electron microscopy (TEM) of
sorted cells. Total colon cells were ﬁrst gated on CD11b+Ly6C+
cells and then were further divided by Ly6G, F4/80, and side-scatter
levels (Fig. 1B and Fig. S1 A and B). Recruited innate cells include
a distinct population of neutrophils (CD11b+Ly6CintLy6G+F4/80−)
with multilobed nuclei and characteristic granules, eosinophils
(CD11b+Ly6Clo/intLy6G−F4/80+SSChi) with distinct cationic gran-
ules, and monocytes/macrophages (CD11b+Ly6Cint/hiLy6G−F4/
80+SSClo) with characteristic nuclear morphology and phagocytic
vesicles (Fig. 1C). Direct epithelial cell damage and signals initiated
by an abnormal localization of microbial ﬂora fuel this inﬂux of
innate cells (Fig. S2 A and B).
The recruitment of granulocytes and macrophages correlated
with amarked increase in IL-22 expression in the middle and distal
colon at the end of the ﬁrst week ofDSS treatment (Fig. 1D). IL-22
production at this early stage is crucial to limit epithelial cell
damage (Fig. S3A), suggesting that recruited innate cell(s) that
express IL-22 might contribute to the maintenance of colonic
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epithelial integrity. Importantly, IL-23 was required for the en-
hanced colonic IL-22 expression during DSS-induced colitis (Fig.
1E), because IL-22 production was ablated in IL-23–deﬁcient
mice. Furthermore, Myd88−/− mice had severely blunted IL-22
production, indicating that microbial responses contribute to
the IL-22 levels in the colon during DSS-induced colitis (Fig.
S3B). Together, these data imply that IL-23–dependent IL-22
expression by recruited innate inﬂammatory cells promotes epi-
thelial protection during acute colitis.
Colonic Neutrophils Respond to IL-23 and TNF-α to Produce IL-22.
Cytokines other than IL-23 can enhance IL-22 production by in-
nate immune cells (1, 26, 27). Moreover, Tnf−/− mice challenged
with DSS have enhanced inﬂammation and colonic epithelial
damage in the colon and succumb to DSS-induced colitis (28, 29).
Therefore, we questioned whether IL-23 in the presence or ab-
sence of TNF-α signals could induce IL-22 production by colonic
granulocytes and/or macrophages. Sorted colonic neutrophils
stimulated with IL-23 up-regulated IL-22 and IL-17 protein levels,
and the addition of TNF-α further enhanced IL-22 production
(Fig. 2A). Although TNF-α signals lead to the up-regulation of
IL-6 and macrophage inﬂammatory protein 2 (MIP-2) in colonic
eosinophil and macrophage populations, it was not sufﬁcient
to induce IL-22 secretion. The expression of IL-22 by colon-
inﬁltrating neutrophils was not unique, because neutrophils iso-
lated from the lungs of asthmatic mice, sorted and then stimulated
with IL-23, also secrete IL-22 protein (Fig. S4B).
Unless cultured in the presence of IL-23, isolated colonic neu-
trophils down-regulated IL-22mRNA, suggesting that IL-23 signals
sustain IL-22 expression (Fig. 2B; also see Table S1). In addition,
IL-23 signals may act to promote the maintenance of an IL-22–
producing neutrophil phenotype (Fig. S1C). In this regard, addition
of IL-23 resulted in up-regulation of IL-23R and retinoic acid-
related orphan receptor gT (RORγt) mRNA levels. Colon neu-
trophils also express aryl hydrocarbon receptor (Ahr) mRNA;
however, IL-23 stimulation did not affect Ahr expression. Although
IL-22–producing colonic neutrophils are a subset of those isolated
duringDSS-induced colitis (Fig. 2C), they are recruited to the colon
continuously. Interestingly, we found that IL-22 was present in the
granules of colonic neutrophils (Fig. 2D). Together, these data
deﬁne an innate cell population of mucosal neutrophils that rapidly
produce IL-22 via granule exocytosis in response to IL-23 signals.
Neutrophils Contribute to IL-22 Levels During Colitis and Enhance
Antimicrobial Peptide Production. To address whether neutrophils
are the source of heightened IL-22 during DSS-induced colitis, we
depleted colonic neutrophils using the RB6-8C5 (anti-Gr1) anti-
body. Compared with controls, RB6-8C5–treated mice showed
profound depletion of colonic neutrophils with negligible effect on
the presence of other innate populations (Fig. 3A). Tominimize the
inﬂux of immature neutrophils to the colon in response to systemic
neutrophil depletion, antibodies were given for 6 h in vivo, and then
colons were cultured ex vivo with antibody and complement. The
depletion of neutrophils on day 7 of DSS treatment resulted in
signiﬁcant reduction in IL-22 production from the middle and
distal colon compared with the control-treated group (Fig. 3B).
This result demonstrates that colonic neutrophils augment local
IL-22 levels during acute colitis.
Because DSS treatment is thought to damage epithelial cells
directly, resulting in abnormal inﬂux of microbes, we investigated
whether IL-22–producing neutrophils act to up-regulate antimi-
crobial peptide production in epithelial cells. For these studies, we
used an epithelial cell line, YAMC, derived from colons of young
adult mice (30). Colonic neutrophils from DSS-treated or lung
neutrophils from asthmatic mice were cocultured with YAMC
epithelial cells, and IL-23 was added to the cultures to sustain
IL-22 production. IL-23–stimulated neutrophils fromDSS-treated
WT mice induced a two- to threefold increase in S100A8 and
S100A9 antimicrobial peptide mRNA in YAMC cells compared
with IL-23–stimulated neutrophils from DSS-treated Il22−/− (KO)
mice (Fig. 3 C and D). Similar results were observed using neu-
trophils sorted from lungs of asthmatic mice (Fig. S4C). Because
neutrophils can express S100A mRNA, the contribution of neu-
trophil-derived IL-22 in the observed induction of epithelial
cell-derived S100A mRNA was assessed both by using colonic
neutrophils from DSS-treated Il22−/− mice and by including a
blocking anti–IL-22 antibody (Fig. 3 C and D). The results establish
that IL-22 produced by mucosal neutrophils up-regulates the ex-
pression of antimicrobial peptide mRNA by colonic epithelial cells.
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Fig. 1. Heightened IL-23–dependent IL-22 expression correlates with the inﬂux
of macrophages and granulocytes during DSS-induced colitis. (A) Cells isolated
from colons of DSS-treated BL/6 mice at various time points were stained with
anti-CD11b and anti-Ly6C and were analyzed by ﬂow cytometry. (B and C)
CD11b+Ly6C+ colon cells were fractionated further into Ly6G+F4/80− neutrophils
(red), Ly6G−F4/80+SSClo macrophages (green), and Ly6G−F4/80+SSChi eosinophils
(blue) (B) and were sorted and examined by TEM (C). (Scale bar, 500 nm.) (D and
E) Colon tissue from DSS-treated BL/6mice (D) and Il23a−/−mice (E) was collected
at different time points and cultured for 2.5–3 d. Supernatant was analyzed for
IL-22 protein by ELISA. Data are representative of three independent experi-
ments with four or ﬁve mice per time point. *P < 0.05.
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IL-22–Producing Neutrophils Contribute to the Resolution of Colitis.
In view of our ﬁndings that inﬁltrating neutrophils produce IL-22
that might contribute to epithelial integrity and antimicrobial
peptide production following DSS-mediated injury, we estab-
lished a model to assess the ability of transferred neutrophils to
protect colitic mice. Neutrophils were generated from cultures of
bone marrow from WT or Il22−/− mice (CD11b+Ly6B.2 (7/4)+
FSCintSSCint) and were transferred into IL-22–deﬁcient recipient
mice on day 4 of DSS treatment (when neutrophils relocate to
the colon). Recipient mice were killed 2 d later (day 6 of treat-
ment), and the severity of colitis and epithelial damage was
scored, and the production of antimicrobial peptides by the co-
lonic epithelium was assessed (Fig. 4).
In mice that did not receive transfers of neutrophils, epithelial
damage in the middle and distal colons of Il22−/− (KO) mice was
increased signiﬁcantly compared with that ofWTmice on day 6 of
DSS treatment (Fig. 4 A and B). This increase was associated with
a marked decrement in the production of RegIIIβ and S100A8
peptides by the colonic epithelium of IL-22–deﬁcient mice (Fig. 4
C and D). The transfer of neutrophils derived from Il22−/− mice
into DSS-treated Il22−/− mice (KO → KO) did not signiﬁcantly
alter colon pathology (Fig. 4 A and B), nor did it rescue pro-
duction of antimicrobial peptide (Fig. 4 C andD). In contrast, the
transfer of bone marrow-derived neutrophils from WT mice to
DSS-treated Il22−/− mice (WT → KO) resulted in signiﬁcant
protection of the colon from DSS-induced epithelial cell damage,
which correlated with enhanced expression of RegIIIβ and
S100A8 peptides by colonic epithelial cells (Fig. 4 A–D).
To quantitate alterations in antimicrobial peptide produc-
tion that resulted from neutrophil-speciﬁc deﬁciency of IL-22,
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Fig. 2. IL-23 with TNF-α signals augments IL-22 production from colonic neutrophils. (A) Cells sorted from the colons of DSS-treated mice were cultured for
48–72 h in the presence or absence of IL-23, TNF-α, or IL-23 + TNF-α. Supernatants were analyzed for IL-22, IL-17, IL-6, and MIP-2 protein by ELISA. ND, not
detected. (B) Colonic neutrophils from DSS-treated BL/6 mice were sorted, and RNA was collected from cells immediately ex vivo or after in vitro culture in the
presence or absence of IL-23. mRNA encoding IL-22, IL-23R, RORγt, or Ahr was quantitated by real-time PCR and was normalized to GAPDH. Data in A and B
are representative of three independent experiments in which colon cells from 10–30 DSS-treated mice were pooled and sorted. (C) Colon cells from DSS-
treated BL/6 and Il22a−/− mice were cultured with IL-23 for 4 h, stained for intracellular IL-22, and then analyzed by ﬂow cytometry. (D) Colonic neutrophils
sorted from DSS-treated BL/6 and Il22a−/− mice were cultured with IL-23 for 4 h, cytospun, and then stained with anti–IL-22 (red). Data in C and D are
representative of two independent experiments with four or ﬁve mice per group.
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laser-capture microdissection (LCM) was used (Fig. 4 E and F).
Epithelial cells isolated from DSS-treated WT mice (WT) ex-
pressed>15–fold higher RegIIIβ and S100A8mRNAas compared
with DSS-treated Il22−/− mice (KO) mice. The transfer of bone
marrow-derived neutrophils from Il22−/− mice into DSS-treated
Il22−/−mice (KO→KO) had no detectable effect on antimicrobial
peptide levels, whereas transfers of WT neutrophils (WT→ KO)
rescued RegIIIβ or S100A8 mRNA expression by colonic epithe-
lial cells. Thus, neutrophil-derived IL-22 signiﬁcantly ameliorates
the severity of DSS-induced epithelial damage and restores anti-
microbial peptide protection.
Discussion
In this study, we ﬁnd that colon-inﬁltrating neutrophils produce
IL-22 in response to coordinated signaling by IL-23 and TNF-α,
establishing a role for granulocytes in supporting enhanced epi-
thelial barrier function. Consistent with our ﬁndings, mice with
defective colonic recruitment of neutrophils caused by CXCR2
deﬁciency had impaired resistance to the rodent intestinal patho-
gen, C. rodentium (24), protection against which is highly de-
pendent on IL-23–induced IL-22 (9, 31). Therefore, neutrophils
recruited to the colon during the acute phase of colitis have a dual
role in host protection: directly killing microbes and indirectly sig-
naling epithelial cells via IL-22/IL-22R to amplify antimicrobial
peptide production and enhance barrier function.
MyD88/TNF-α signals that are triggered in response to trans-
cytosed microbes or their proinﬂammatory products contribute to
increased IL-22 production in the colons of DSS-treated mice (Fig.
S2B). In this regard, several published reports indicate that colonic
macrophages serve a protective role inDSS-induced colitis (32, 33).
Because, in addition to IL-23, colonic macrophages produce
abundant TNF-α during DSS-induced colitis (34), colonic macro-
phages and IL-22–producing colonic neutrophils likely cooperate
to protect the epithelial barrier during acute colitis, where there is
coincident recruitment of both cell populations (Fig. 1). Notably, it
has been reported that patients with psoriasis treatedwith theTNF-
α inhibitor, etanercept (TNFRII-Fc), had decreased levels of IL-17
and IL-22 in their serum (27). Although this ﬁnding could reﬂect
a global reduction in inﬂammation, it also is conceivable that TNF-
α blockade might result in dampening of IL-22 production, an ef-
fect that could be detrimental to the restoration of epithelial in-
tegrity in colitis. This possibility will require further study.
The ﬁnding that colon-recruited neutrophils represent a critical
source of IL-22 for restoration of epithelial integrity suggests that
sustained production of IL-22 requires coordinate interplay with
other innate immune cells previously identiﬁed as sources of IL-22
in the response to mucosal injury or inﬂammation (e.g., ILC sub-
types, NK cells, dendritic cells, and γδ T cells). However, during
acute colitis, rapid release of granule-packaged IL-22 from colonic
neutrophils may be more beneﬁcial than IL-22 production from
other innate and lymphocyte populations, which can take hours to
days. The production of IL-22 by such a variety of cell types no
doubt reﬂects the indispensible role of this cytokine in maintaining
and repairing the intestinal barrier. In this regard,NK1.1+ cells have
been shown to contribute to IL-22 levels in the colon around day 4
after initiation of DSS treatment (4), preceding the recruitment
of peak numbers of IL-22–producing neutrophils around days 6–8
after DSS treatment (Fig. 1A), which, in turn, precedes the de-
velopment and recruitment of Th17 or Th22 cells around days
10–12 after DSS treatment (35). Therefore, various IL-22–producing
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cells contribute to the maintenance or restitution of epithelial in-
tegrity at different stages of disease, supporting a sequential re-
cruitment model in which different components of the innate and
adaptive immune system are orchestrated for sustained production
of IL-22. Alternatively, or perhaps in addition, different populations
of IL-22–producing cells might contribute to regional resolution of
colitis. In future studies it will be important to consider several
factors in understanding the interplay of innate and adaptive im-
mune cells that produce IL-22: (i) the schedule of recruitment
to the colon, (ii) regional positioning of cells, and (iii) potential
targeting of different IL-22R–expressing cells.
Unlike other IL-22–producing innate immune cell populations,
neutrophils are nonresidents of the colon and are recruited in
large numbers in response to mucosal injury. In addition to IL-22,
neutrophils also express IL-17 in response to IL-23 (ref. 36 and
Fig. 2A); both are cytokines classically produced by Th17 cells.
Because neutrophils are short-lived cells and must be recruited to
the colon continuously, it is of interest that Th17 cells promote the
enhanced recruitment of neutrophils to inﬂammatory sites, both
through their production of factors that increase neutrophil pro-
duction by the bone marrow, whether directly (e.g., GM-CSF) or
indirectly (e.g., IL-17–induced granulocyte colony-stimulating fac-
tor, G-CSF), and their production or induction of chemokines that
recruit neutrophils (e.g., IL-8). The ﬁndings herein therefore
identify a previously unappreciated connection in the Th17–neu-
trophil axis, wherein sustained recruitment of neutrophils that
results from Th17-driven chronic inﬂammation could serve as an
important mechanism for both amplifying IL-22–dependent pro-
tective effects on the epithelium and eliminating microbes that
breach the injured epithelial barrier.
Materials and Methods
Mice. C57BL/6 mice were purchased from Jackson Laboratories. Il22−/− mice
were a gift fromW. Ouyang (Genetech, South San Francisco, CA) (37). Il23a−/−
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mice were provided by Schering-Plough/Merck. All animals were bred and
maintained at the University of Alabama at Birmingham (UAB) in accordance
with the UAB Institutional Animal Care and Use Committee regulations.
DSS Model of Colitis. Mice were treated with 2.5–3% (wt/vol) DSS (MP Bio-
medicals; molecular weight: 36,000–50,000) in their drinking water for 7
d and then were switched to sterile tap water. DSS-treated mice were
monitored regularly for signs of disease.
Ex Vivo Colon Cultures. Colon tissue was ﬂushed, cut into three equal sections
(proximal, middle, distal), and then was opened longitudinally. Individual
tissue segments were placed in 0.4 mL of R10 medium [Roswell Park
Memorial Institute (RPMI) medium 1640 supplemented with 10% (vol/vol) FCS,
penicillin (100 IU/mL), streptomycin (100 μg/mL), 1× nonessential amino acids
(NEAA), sodium pyruvate (1 μM), β-mercaptoethanol (2.5 μM), and L-glu-
tamine (2 μM)] in a 24-well culture plate and were incubated for 2–3 d at
37 °C, 5% CO2.
Depletion of Neutrophils. DSS-treated mice were administered 100 μg of ei-
ther anti-rat IgG (Control; Sigma) or anti-Gr1 (RB6-8C5) for 6–18 h. Colon
tissue was cultured as described above. Media were supplemented with
10 μg of either anti-rat Ig or anti-Gr1, respectively, and Low-Tox rabbit
complement (Colorado Serum Co.).
LCM. Unﬁxed colon tissue frozen in O.C.T. compound (Tissue-Tek) in 6-μm
sections on PEN-membrane glass slides (Applied Biosystems) was stained
with Cresyl Violet dye (Ambion). Stained epithelial cells (1,000 per cap) were
captured on Arcturus HS LCM caps (Applied Biosystems) using a Veritas LCM
instrument. RNA was extracted using the Arcturus PicoPure RNA isolation kit
(Applied Biosystems). DNA was degraded using an RNase-free DNase
set (Qiagen).
Epithelial Cell Cultures. Conditionally immortalized YAMC cells were kindly
provided by R. H. Whitehead (Vanderbilt University, Nashville, TN) (30). Cells
were maintained at 33 °C in RPMI 1640 containing 5% FBS (vol/vol), 1 μg/mL
insulin, 10 μM α-thioglycerol, 1 μM hydrocortisone, and 10 U/mL IFN-γ. Cells
(3.5 × 105) were seeded into 12-well culture plates and incubated overnight
at 37 °C without IFN-γ. The next day, the medium was changed to R10 before
the addition of 10 ng/mL IL-23 and 3 × 105 neutrophils. Two days later,
YAMC cells were washed and processed for RNA isolation using an RNeasy
Mini kit (Qiagen).
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